Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus

被引：3

作者：

Finucane, K. A. ^{[1
]}

Archer, C. B. ^{[1
]}

机构：

[1] Univ Hosp Bristol NHS Fdn Trust, Bristol Dermatol Ctr, Bristol, Avon, England

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2010年 / 35卷 / 01期

关键词：

D O I：

10.1111/j.1365-2230.2009.03526.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

This is the sixth in a series of CPD articles aimed at reviewing the recent general medical literature relating to topics that may be of interest to dermatologists. In this issue the new classes of anti-retroviral drugs will be described in the context of the replication cycle of human immunodeficiency virus (HIV). The regimens of drug treatments and the more common side-effects including HIV-lipodystrophy syndrome will be discussed along with the recommendations for testing of people for HIV from new guidelines.

引用

页码：107 / 109

页数：3

共 50 条

[21] Human immunodeficiency virus-related opportunistic infections in the era of highly active antiretroviral therapy
Masur, H
EMERGING INFECTIONS 4, 2000, : 165 - 186
[22] Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma
Bower, Mark
Powles, Tom
Nelson, Mark
Mandalia, Sundhiya
Gazzard, Brian
Stebbing, Justin
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (15): : 1088 - 1091
[23] Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy
Pakkala, Suchita
Chen, Zhengjia
Rimland, David
Owonikoko, Taofeek K.
Gunthel, Clifford
Brandes, Johann R.
Saba, Nabil R.
Shin, Dong M.
Curran, Walter J., Jr.
Khuri, Fadlo R.
Ramalingam, Suresh S.
CANCER, 2012, 118 (01) : 164 - 172
[24] Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy
Nachman, SA
Lindsey, JC
Moye, J
Stanley, KE
Johnson, GM
Krogstad, PA
Wiznia, AA
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (04) : 352 - 357
[25] Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection
Heath, KV
Montaner, JSG
Bondy, G
Singer, J
O'Shaughnessy, MV
Hogg, RS
CURRENT DRUG TARGETS, 2003, 4 (01) : 13 - 22
[26] Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults
Appleby, P
Beral, V
Newton, R
Reeves, G
Carpenter, L
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (22): : 1823 - 1830
[27] Physical Fitness in Children Infected with the Human Immunodeficiency Virus: Associations with Highly Active Antiretroviral Therapy
Somarriba, Gabriel
Lopez-Mitnik, Gabriela
Ludwig, David A.
Neri, Daniela
Schaefer, Natasha
Lipshultz, Steven E.
Scott, Gwendolyn B.
Miller, Tracie L.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 112 - 120
[28] Impact of highly active antiretroviral therapy on outcome of cholecystectomy in patients with human immunodeficiency virus infection
Foschi, D.
Cellerino, P.
Corsi, F.
Casali, A.
Rizzi, A.
Righi, I.
Trabucchi, E.
BRITISH JOURNAL OF SURGERY, 2006, 93 (11) : 1383 - 1389
[29] Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era
Pinheiro, Raquel dos Santos
Franca, Talita Tenorio
Beder Ribeiro, Camila Maria
Leao, Jair Carneiro
Ribeiro de Souza, Ivete Pomarico
Castro, Gloria Fernanda
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2009, 38 (08) : 613 - 622
[30] Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy
O'Sullivan, CE
Drew, WL
McMullen, DJ
Miner, R
Lee, JY
Kaslow, RA
Lazar, JG
Saag, MS
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03): : 847 - 849

← 1 2 3 4 5 →